Logo image of CBAN

COLONY BANKCORP (CBAN) Stock Fundamental Analysis

NYSE:CBAN - New York Stock Exchange, Inc. - US19623P1012 - Common Stock - Currency: USD

15.41  -0.11 (-0.71%)

After market: 15.41 0 (0%)

Fundamental Rating

4

Overall CBAN gets a fundamental rating of 4 out of 10. We evaluated CBAN against 398 industry peers in the Banks industry. CBAN has a bad profitability rating. Also its financial health evaluation is rather negative. CBAN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CBAN had positive earnings in the past year.
In the past year CBAN had a positive cash flow from operations.
Each year in the past 5 years CBAN has been profitable.
Of the past 5 years CBAN 4 years had a positive operating cash flow.
CBAN Yearly Net Income VS EBIT VS OCF VS FCFCBAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.77%, CBAN is in line with its industry, outperforming 44.72% of the companies in the same industry.
CBAN has a Return On Equity (8.56%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.77%
ROE 8.56%
ROIC N/A
ROA(3y)0.71%
ROA(5y)0.7%
ROE(3y)8.52%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
CBAN Yearly ROA, ROE, ROICCBAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

CBAN has a Profit Margin of 20.67%. This is in the lower half of the industry: CBAN underperforms 60.55% of its industry peers.
In the last couple of years the Profit Margin of CBAN has grown nicely.
The Operating Margin and Gross Margin are not available for CBAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 20.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.26%
PM growth 5Y4.61%
GM growth 3YN/A
GM growth 5YN/A
CBAN Yearly Profit, Operating, Gross MarginsCBAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

CBAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBAN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CBAN has been increased compared to 5 years ago.
The debt/assets ratio for CBAN has been reduced compared to a year ago.
CBAN Yearly Shares OutstandingCBAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CBAN Yearly Total Debt VS Total AssetsCBAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CBAN has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as CBAN would need 2.82 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.82, CBAN is in line with its industry, outperforming 41.71% of the companies in the same industry.
CBAN has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, CBAN is in line with its industry, outperforming 41.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.82
Altman-Z N/A
ROIC/WACCN/A
WACC14.96%
CBAN Yearly LT Debt VS Equity VS FCFCBAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBAN Yearly Current Assets VS Current LiabilitesCBAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.72% over the past year.
CBAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.95% yearly.
CBAN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.38%.
Measured over the past years, CBAN shows a quite strong growth in Revenue. The Revenue has been growing by 13.31% on average per year.
EPS 1Y (TTM)11.72%
EPS 3Y-12.13%
EPS 5Y3.95%
EPS Q2Q%26.67%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y4.05%
Revenue growth 5Y13.31%
Sales Q2Q%6.61%

3.2 Future

Based on estimates for the next years, CBAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.71% on average per year.
Based on estimates for the next years, CBAN will show a small growth in Revenue. The Revenue will grow by 7.82% on average per year.
EPS Next Y25.04%
EPS Next 2Y18.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.17%
Revenue Next 2Y7.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBAN Yearly Revenue VS EstimatesCBAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CBAN Yearly EPS VS EstimatesCBAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

CBAN is valuated reasonably with a Price/Earnings ratio of 10.78.
Based on the Price/Earnings ratio, CBAN is valued a bit cheaper than the industry average as 62.31% of the companies are valued more expensively.
CBAN is valuated cheaply when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.10, which indicates a very decent valuation of CBAN.
77.14% of the companies in the same industry are more expensive than CBAN, based on the Price/Forward Earnings ratio.
CBAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.78
Fwd PE 8.1
CBAN Price Earnings VS Forward Price EarningsCBAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBAN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.07
EV/EBITDA N/A
CBAN Per share dataCBAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBAN's earnings are expected to grow with 18.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)2.73
EPS Next 2Y18.71%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.98%, CBAN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.58, CBAN has a dividend in line with its industry peers.
CBAN's Dividend Yield is comparable with the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 2.98%

5.2 History

The dividend of CBAN is nicely growing with an annual growth rate of 8.42%!
CBAN has been paying a dividend for at least 10 years, so it has a reliable track record.
CBAN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.42%
Div Incr Years2
Div Non Decr Years2
CBAN Yearly Dividends per shareCBAN Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

33.09% of the earnings are spent on dividend by CBAN. This is a low number and sustainable payout ratio.
CBAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP33.09%
EPS Next 2Y18.71%
EPS Next 3YN/A
CBAN Yearly Income VS Free CF VS DividendCBAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
CBAN Dividend Payout.CBAN Dividend Payout, showing the Payout Ratio.CBAN Dividend Payout.PayoutRetained Earnings

COLONY BANKCORP

NYSE:CBAN (4/25/2025, 8:04:00 PM)

After market: 15.41 0 (0%)

15.41

-0.11 (-0.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners57.9%
Inst Owner Change-0.07%
Ins Owners3.84%
Ins Owner Change0.02%
Market Cap269.37M
Analysts80
Price Target19.51 (26.61%)
Short Float %0.57%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 2.98%
Yearly Dividend0.45
Dividend Growth(5Y)8.42%
DP33.09%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-05 2025-02-05 (0.115)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.72%
Min EPS beat(2)-3.47%
Max EPS beat(2)22.91%
EPS beat(4)1
Avg EPS beat(4)3.49%
Min EPS beat(4)-5.12%
Max EPS beat(4)22.91%
EPS beat(8)3
Avg EPS beat(8)4.12%
EPS beat(12)3
Avg EPS beat(12)-2.93%
EPS beat(16)5
Avg EPS beat(16)2.86%
Revenue beat(2)1
Avg Revenue beat(2)1.1%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)4.42%
Revenue beat(4)1
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)4.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.29%
Revenue beat(12)2
Avg Revenue beat(12)-2.97%
Revenue beat(16)6
Avg Revenue beat(16)-1.87%
PT rev (1m)0%
PT rev (3m)0.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.3%
EPS NY rev (3m)7.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)2.94%
Valuation
Industry RankSector Rank
PE 10.78
Fwd PE 8.1
P/S 2.33
P/FCF 12.07
P/OCF 11.51
P/B 0.97
P/tB 1.19
EV/EBITDA N/A
EPS(TTM)1.43
EY9.28%
EPS(NY)1.9
Fwd EY12.34%
FCF(TTM)1.28
FCFY8.29%
OCF(TTM)1.34
OCFY8.69%
SpS6.6
BVpS15.94
TBVpS12.97
PEG (NY)0.43
PEG (5Y)2.73
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 8.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.67%
GM N/A
FCFM 19.33%
ROA(3y)0.71%
ROA(5y)0.7%
ROE(3y)8.52%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.26%
PM growth 5Y4.61%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.82
Debt/EBITDA N/A
Cap/Depr 13.28%
Cap/Sales 0.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 93.52%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC14.96%
ROIC/WACCN/A
Cap/Depr(3y)26.6%
Cap/Depr(5y)43.96%
Cap/Sales(3y)2.21%
Cap/Sales(5y)3.53%
Profit Quality(3y)137.86%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3Y-12.13%
EPS 5Y3.95%
EPS Q2Q%26.67%
EPS Next Y25.04%
EPS Next 2Y18.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.38%
Revenue growth 3Y4.05%
Revenue growth 5Y13.31%
Sales Q2Q%6.61%
Revenue Next Year9.17%
Revenue Next 2Y7.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.54%
FCF growth 3Y-9.65%
FCF growth 5Y124.66%
OCF growth 1Y11.52%
OCF growth 3Y-13.45%
OCF growth 5Y43.25%